To successfully meet compliance demands, pharmaceutical manufacturers must develop, implement, and track the effectiveness of a company-wide compliance strategy. Key to that strategy is to adopt industry-specific enterprise software with functionality that supports Federal Drug Administration (FDA) requirements. Learn more about the criteria and recommendations you need to achieve compliance in the pharmaceutical industry.
drug maker's cGMP infractions. Violating the Federal Food, Drug, and Cosmetic Act could result in product seizures, injunction, and criminal prosecution with penalties of up to a year in jail and a $100,000 (USD) fine for each noncompliant shipment or act. So the obvious question is: Why, if FDA regulations are well known and noncompliance is so costly, are pharmaceutical manufacturers still making avoidable compliance mistakes? The problem for many companies often lies in the reality of running a